Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy? 1 1Abbreviations: NSAIDs, nonsteroidal anti-inflammatory drugs; COX, cyclooxygenase; LT, leukotriene; 5-LOX, 5-lipoxygenase; PG, prostaglandin; DFU, 5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsuphonyl)-phenyl-2(5H)-furanone; and DFP, diisopropyl fluorophosphate.
- 26 November 2001
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 62 (11) , 1433-1438
- https://doi.org/10.1016/s0006-2952(01)00747-x
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Cyclo‐oxygenase‐2: pharmacology, physiology, biochemistry and relevance to NSAID therapyBritish Journal of Pharmacology, 1999
- COX-2 inhibitorsThe Lancet, 1999
- Expression of cyclo‐oxygenase‐2 in human airway smooth muscle is associated with profound reductions in cell growthBritish Journal of Pharmacology, 1998
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- The PPARα–leukotriene B4 pathway to inflammation controlNature, 1996
- Up‐regulation of cyclooxygenase‐2 mRNA in the rat spinal cord following peripheral inflammationFEBS Letters, 1996
- Cytokine-modulating activity of tepoxalin, a new potential antirheumaticInternational Journal of Immunopharmacology, 1995
- Leukotrienes as a Target in Asthma TherapyDrugs, 1994
- Leukotrienes and Prostaglandins in AsthmaAllergy, 1984
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980